Skip to main navigation Skip to search Skip to main content

Cochrane drugs and alcohol group: The development of systematic reviews of treatment outcome

  • R. P. Mattick
  • , R. Ali
  • , M. Auriacombe
  • , M. Davoli
  • , F. Faggiano
  • , M. Farrell
  • , M. Ferri
  • , W. Ling

Research output: Contribution to journalComment/debate

Abstract

The aim of the Cochrane Collaboration is to promote review processes which address all aspects of health care and which can be viewed by clinicians to guide their day-to-day clinical practice. Recently, a Cochrane review group on drugs and alcohol has been developed. The Cochrane Review Group Editorial base is in Rome, Italy. There is an international editorial board with editors in the UK, Italy, France, Australia and the USA. So far, the group has published five reviews addressing treatment for opioid, cocaine and alcohol dependence. Additional reviews and protocols are in progress. A growing number of titles are registered with the group. Interested readers and potential reviewers and/or referees can contact the Cochrane Drugs and Alcohol Group Coordinator in Rome at the e-mail address: dacochraneαsplazio.it.

Original languageEnglish
Pages (from-to)109-111
Number of pages3
JournalAlcohol and Alcoholism
Volume36
Issue number2
DOIs
Publication statusPublished - 2001
Externally publishedYes

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'Cochrane drugs and alcohol group: The development of systematic reviews of treatment outcome'. Together they form a unique fingerprint.

Cite this